Life Sciences Sector

Rewriting the Code of Life Sciences CRE

 

The life sciences industry has experienced major upheavals in recent years. The changing healthcare landscape, patent cliff, tighter regulations and pricing pressures have forced life sciences companies to reconsider their business models and revamp organizational structures. The changes in the sector have inevitably affected corporate real estate, demanding innovative solutions that can support overarching corporate strategy.

This report identifies three major trends for CRE in life sciences from JLL’s 2013 Global Corporate Real Estate Survey. It also discusses the evolution required for CRE teams to maximize their strategic value in the fast-changing life sciences industry.

Download our infographic

Learn more

View a short presentation of the results

Learn more

View our ebook

Learn more

Where do you stand?

Learn more

 

Download our infographic

Learn more
View a short presentation of the results

Learn more
View our ebook

Learn more
Where do you stand?

Learn more

Three CRE trends for the life sciences sector:

1- CRE success hampered by a disconnect with the C-suite

2- Strong demands for portfolio optimization

3- Regional portfolio reshuffle